Frequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE)
Top Cited Papers
Open Access
- 6 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Neuropathologica Communications
- Vol. 9 (1), 1-13
- https://doi.org/10.1186/s40478-020-01085-3
Abstract
Focal malformations of cortical development (MCD) are linked to somatic brain mutations occurring during neurodevelopment. Mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE) is a newly recognized clinico-pathological entity associated with pediatric drug-resistant focal epilepsy, and amenable to neurosurgical treatment. MOGHE is histopathologically characterized by clusters of increased oligodendroglial cell densities, patchy zones of hypomyelination, and heterotopic neurons in the white matter. The molecular etiology of MOGHE remained unknown so far. We hypothesized a contribution of mosaic brain variants and performed deep targeted gene sequencing on 20 surgical MOGHE brain samples from a single-center cohort of pediatric patients. We identified somatic pathogenic SLC35A2 variants in 9/20 (45%) patients with mosaic rates ranging from 7 to 52%. SLC35A2 encodes a UDP-galactose transporter, previously implicated in other malformations of cortical development (MCD) and a rare type of congenital disorder of glycosylation. To further clarify the histological features of SLC35A2-brain tissues, we then collected 17 samples with pathogenic SLC35A2 variants from a multicenter cohort of MCD cases. Histopathological reassessment including anti-Olig2 staining confirmed a MOGHE diagnosis in all cases. Analysis by droplet digital PCR of pools of microdissected cells from one MOGHE tissue revealed a variant enrichment in clustered oligodendroglial cells and heterotopic neurons. Through an international consortium, we assembled an unprecedented series of 26 SLC35A2-MOGHE cases providing evidence that mosaic SLC35A2 variants, likely occurred in a neuroglial progenitor cell during brain development, are a genetic marker for MOGHE.Keywords
Funding Information
- European Research Council (682345)
- Program "Investissements d'avenir" (ANR-10-IAIHU-06, ANR-18-RHUS-005)
- Health Research and Development (ZonMw) and Epilepsiefonds
- Suh Kyungbae Foundation
- National Research Foundation of Korea (NRF) grant funded by the Korea Government, Ministry of Science and ICT (2019R1A3B2066619)
This publication has 40 references indexed in Scilit:
- The role of protein N-glycosylation in neural transmissionGlycobiology, 2014
- Myelin‐specific proteins: A structurally diverse group of membrane‐interacting moleculesBioFactors, 2013
- UDP‐N‐acetylglucosamine transporter and UDP‐galactose transporter form heterologous complexes in the Golgi membraneFEBS Letters, 2012
- Neurology of inherited glycosylation disordersThe Lancet Neurology, 2012
- Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRIActa Neuropathologica, 2011
- The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1Epilepsia, 2010
- Participation of galactosylceramide and sulfatide in glycosynapses between oligodendrocyte or myelin membranesFEBS Letters, 2009
- Oligodendrocyte Development and Myelin Biogenesis: Parsing Out the Roles of GlycosphingolipidsPhysiology, 2009
- Polysialic Acid-Directed Migration and Differentiation of Neural Precursors Are Essential for Mouse Brain DevelopmentMolecular and Cellular Biology, 2007
- Epilepsy in childrenThe Lancet, 2006